CMPS · Compass Pathways Plc ADR
United States · RS rating 35 · As of 2026-11-03
| Price | 8.59 USD |
|---|---|
| 1-day change | +2.1% |
| RS rating (overall / 1M / 3M / 12M) | 35 / 15 / 16 / 78 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 35 / 37 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +30.6% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +43.5% |
| Market cap (USD) | $1.2B |